Company profile for Tessellate BIO

Tessellate BIO

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

Contact Supplier

Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

pharmacompass-2-2026-02-09

Contact Supplier

VIRTUAL BOOTH
CONTACT DETAILS
Google Map, LinkedIn, Emails...

DIGITAL CONTENT

8 News #PharmaBuzz

media
8 News #PharmaBuzz

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Tessellate BIO was founded to develop precision oncology approaches to treat cancers with high unmet needs. We are initially focusing on validated targets to address the group of cancers that depend on the alternative lengthening of telomeres (ALT) which can be detected with our proprietary companion diagnostic. In parallel, we are building an innovative pipeline by exploiting synthetic lethal targets in three areas: DNA damag...

Tessellate BIO was founded to develop precision oncology approaches to treat cancers with high unmet needs. We are initially focusing on validated targets to address the group of cancers that depend on the alternative lengthening of telomeres (ALT) which can be detected with our proprietary companion diagnostic. In parallel, we are building an innovative pipeline by exploiting synthetic lethal targets in three areas: DNA damage response pathways, loss-of-function of tumor suppressors, and paralog pairs.

Clinical OutsourcingClinical Outsourcing

Not Confirmed

Not Confirmed

03-04 March, 2026

Copthorne Tara Hotel, London Kensington, United Ki
Natural Product Expo W...Natural Product Expo West

Not Confirmed

Not Confirmed

03-06 March, 2026

California, U.S.A
Natural Products ExpoNatural Products Expo

Not Confirmed

Not Confirmed

03-06 March, 2026

California, U.S.A

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown

Netherlands1 Flag

Country

Country

Netherlands

Address

Address

Gooimer 235 1411 DC Naarden

Telephone

Telephone

Email

enquiries@pharmacompass.com

Client Website

Website

https://tessellatebio.com/

Linkedin

https://www.linkedin.com/company/tessellatebio/

youtube

YouTube

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

Tessellate Bio Appoints Katie Chapman As Chief Scientific Officer

02 Oct 2025

// PHARMAWEB

Tessellate Bio Appoints Katie Chapman As Chief Scientific Officer

01 Oct 2025

// GLOBENEWSWIRE

Boehringer slots synthetic lethal program into oncology pipeline

23 Apr 2025

// FIERCE BIOTECH

Tessellate BIO Appoints Lara Boyd as Chief Business Officer

04 Nov 2024

// GLOBENEWSWIRE

Tessellate BIO, Omico & CMRI Announce Collab For ALT Cancers

30 Sep 2024

// GLOBENEWSWIRE

Tessellate Appoints Prof. Sandra Strauss To Scientific Advisory Board

01 May 2024

// GLOBENEWSWIRE

Drugs in Development

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Market Place

Home

Menu

Post Enquiry

Market Place

Search